Capmatinib

Back to search

Molecule Structure

Scientific Name

Capmatinib

Description of the Drug

Capmatinib is a kinase inhibitor targeting c-Met receptor tyrosine kinase in the treatment of non-small cell lung cancer with MET exon 14 skipping.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB11791

Brand Name(s)

Not Available

Company Owner(s)

Novartis Pharmaceutical Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Hepatocyte growth factor receptor SINGLE PROTEIN INHIBITOR CHEMBL3717

Unichem Links

SureChEMBL SCHEMBL1426819
DrugBank DB11791
PubChem: Thomson Pharma 56473134
PubChem 25145656
Nikkaji J3.320.942H
BindingDB 50146167
EPA CompTox Dashboard DTXSID90145595
Brenda 215759
ChemicalBook CB92574678
Guide to Pharmacology 7904
GSRS 76c9ed58-31c2-4191-918f-bf3f79caf0ce
rxnorm CAPMATINIB HYDROCHLORIDE CAPMATINIB
ZINC ZINC000043195321